Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke
Status:
Completed
Trial end date:
2019-10-19
Target enrollment:
Participant gender:
Summary
NBO is a nonpharmacological measure of neuroprotection. The purpose of our study is to
evaluate the safety and efficiency of NBO（Normobaric hyperoxia) in the acute ischemic stroke
patients who received endovascular treatment. Looking for more clinical evidence for the
ischemic stroke patients who will be treated with NBO in the future.